December 05, 2024
Trending Now
1
Obstructive Sleep Apnea Affects nAMD
2
Vision Deficits Associated with Mild Traumatic Brain Injury
3
New TED Drug Positioned for Success
4
Faricimab Shows Better Anatomic Outcomes Compared to Aflibercept for nAMD
5
Sickle Cell Drug Shows Promise in Stabilizing Vision in Rare Genetic Disease
6
Detailed Connections between Geographic Atrophy Lesions and Vision Loss
Conference Coverage
American Academy of Ophthalmology annual meeting
October 01, 2024
Regeneron Leaders Recognized for Innovation at Eyecelerator 2024
October 01, 2024
Hot Topics for the Comprehensive Ophthalmologist
September 01, 2024
An Update on SLT Clinical Trials
American Academy of Optometry annual meeting
November 01, 2024
Life-threatening eye signs and symptoms to keep on your radar
November 01, 2024
Visual field defect testing can be life saving
November 01, 2024
Key indicators of diseases
Clinical Guidelines
View MoreDecember 02, 2024
2024 Vitamin D Guidelines: A Critical Review
November 01, 2023
What's New
May 01, 2023
Virtual Reality in Retina
June 01, 2023
LEADING OFF How AI Could Shape Eye Care
Commentary & Perspectives
View MoreSeptember 01, 2023
VIEWPOINT FROM THE EDITOR
FDA & Government News
View MoreDecember 17, 2024
New TED Drug Positioned for Success
December 16, 2024
Does Ozempic Double Eye Disease Risk?
December 16, 2024
FDA 6-Month Drug Pipeline
December 12, 2024
Is Bausch + Lomb Facing a Sale?
Business Management
View MoreSeptember 01, 2023
EMR and MIPS compliance
December 01, 2023
GUEST EDITORIAL
November 01, 2023
PRACTICE MANAGEMENT STRATEGIES
May 01, 2024